Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
medical symbols : Vive save search
Crown Aesthetics Expands Further into the Asia Pacific Region
Published: 2023-06-05 (Crawled : 11:00) - prnewswire.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
| Email alert
Add to watchlist
asia
Delisting of Securities of Schmitt Industries, Inc.; Viveve Medical, Inc.; and American Virtual Cloud Technologies, Inc. from The Nasdaq Stock Market
Published: 2023-01-23 (Crawled : 22:00) - globenewswire.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 12.83%
H: 9.8%
C: -5.88%
SMIT | $0.0313 26.45% 4.5K
|
Producer Manufacturing
|
| O: 0.0%
H: 1.87%
C: 1.87%
NDAQ | $60.075 0.11% 0.11% 2.3M
|
Finance
|
| O: 0.16%
H: 0.14%
C: -0.8%
market cloud
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence
Published: 2023-01-17 (Crawled : 12:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: -68.41%
H: 3.05%
C: -4.31%
topline trial
Viveve Announces Completion of Pivotal US PURSUIT Trial for Female Stress Urinary Incontinence with Final 12-month Follow-up Visits Concluded
Published: 2022-12-15 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 5.25%
H: 6.89%
C: 6.89%
trial
Viveve Announces Issuance of Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-12-01 (Crawled : 14:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 2.41%
C: -0.21%
patent
Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-10 (Crawled : 22:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 6.67%
H: 0.0%
C: -10.54%
financial update results
Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022
Published: 2022-10-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.25%
report financial update results
Viveve Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence
Published: 2022-10-04 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 4.5%
C: -3.41%
patent
Viveve Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal PURSUIT Trial Readout
Published: 2022-09-27 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 5.22%
H: 1.22%
C: -2.94%
treatment trial readout
Viveve to Participate in Ladenburg Thalmann Healthcare Conference
Published: 2022-09-22 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: -0.25%
H: 1.3%
C: -5.19%
conference
Viveve to Participate in Alliance Global Partners Virtual MedTech Conference
Published: 2022-09-15 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 1.91%
H: 1.67%
C: 0.65%
global conference
Viveve to Participate in H.C. Wainwright 24th Annual Global Investment Conference
Published: 2022-09-01 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 4.94%
H: 0.0%
C: -6.57%
global conference
Viveve Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 20:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: -0.1%
H: 3.07%
C: -2.09%
update results
Viveve to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 11, 2022
Published: 2022-07-28 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.45%
H: 4.8%
C: 4.8%
report update results
Viveve Announces Expansion of IP Portfolio with Patent Issuance in Taiwan
Published: 2022-07-12 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 2.63%
H: 1.75%
C: -1.29%
expansion patent
Viveve to Participate in H.C. Wainwright Global Investment Conference
Published: 2022-05-17 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: -3.78%
H: 11.14%
C: 9.2%
conference
Viveve CEO Scott Durbin Named Among Top 50 Healthcare Technology Leaders of 2022 by Healthcare Technology Report
Published: 2022-05-17 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.0%
H: 6.41%
C: 1.28%
ceo report technology
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-05-12 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 0.51%
H: 4.8%
C: 3.48%
results
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Published: 2022-04-28 (Crawled : 13:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 4.49%
H: 0.86%
C: -2.04%
report results
Viveve Reports Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-17 (Crawled : 21:00) - ir.viveve.com
VIVE | $0.0002 59900.0% 150
|
Health Technology
|
| O: 3.97%
H: 3.96%
C: 3.96%
financial results report results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.